BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24524051)

  • 1. National healthcare budget impact analysis of the treatment for osteoporosis and fractures in Korea.
    Yi H; Ha YC; Lee YK; Lim YT
    J Bone Metab; 2013 May; 20(1):17-23. PubMed ID: 24524051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
    Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
    Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
    Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
    J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the Fiscal Costs of Osteoporosis in Korea Applying a Public Economic Perspective.
    Connolly MP; Panda S; Kim HY
    J Bone Metab; 2019 Nov; 26(4):253-261. PubMed ID: 31832391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The socioeconomic cost of injuries in South Korea].
    Park K; Lee JS; Kim Y; Kim YI; Kim J
    J Prev Med Public Health; 2009 Jan; 42(1):5-11. PubMed ID: 19229119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries.
    Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN
    Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.
    Ray NF; Chan JK; Thamer M; Melton LJ
    J Bone Miner Res; 1997 Jan; 12(1):24-35. PubMed ID: 9240722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial Integration Scenario for Community Integrated Care: Focusing on the Case of Korea.
    Moon B
    Int J Integr Care; 2022; 22(2):18. PubMed ID: 35693296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic Burden of Osteoporosis in South Korea: Claim Data of the National Health Insurance Service from 2008 to 2011.
    Ha YC; Kim HY; Jang S; Lee YK; Kim TY
    Calcif Tissue Int; 2017 Dec; 101(6):623-630. PubMed ID: 28913546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment.
    King AB; Saag KG; Burge RT; Pisu M; Goel N
    Osteoporos Int; 2005 Dec; 16(12):1545-57. PubMed ID: 15942702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study.
    Ku H; Chung WJ; Lee HY; Yoo BS; Choi JO; Han SW; Jang J; Lee EK; Kang SM
    Yonsei Med J; 2017 Sep; 58(5):944-953. PubMed ID: 28792137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical costs of osteoporosis in the elderly Medicare population.
    Blume SW; Curtis JR
    Osteoporos Int; 2011 Jun; 22(6):1835-44. PubMed ID: 21165602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Impact of Atopic Dermatitis in Korean Patients.
    Kim C; Park KY; Ahn S; Kim DH; Li K; Kim DW; Kim MB; Jo SJ; Yim HW; Seo SJ
    Ann Dermatol; 2015 Jun; 27(3):298-305. PubMed ID: 26082587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence.
    Chen M; Si L; Winzenberg TM; Gu J; Jiang Q; Palmer AJ
    Patient Prefer Adherence; 2016; 10():415-23. PubMed ID: 27099477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The societal burden of HBV-related disease: South Korea.
    Yang BM; Kim DJ; Byun KS; Kim HS; Park JW; Shin S
    Dig Dis Sci; 2010 Mar; 55(3):784-93. PubMed ID: 19333757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budget impact analysis of osteoporosis medications for primary prevention of fractures in Taiwan.
    Wu KL; Wu CH; Chang YF; Lin YT; Hsu JC
    J Bone Miner Metab; 2020 May; 38(3):316-327. PubMed ID: 31709455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of improved medication adherence on health care costs in osteoporosis patients.
    Cho H; Byun JH; Song I; Kim HY; Ha YC; Kim TY; Lee YK; Jang S
    Medicine (Baltimore); 2018 Jul; 97(30):e11470. PubMed ID: 30045269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea.
    Choi JA; Song LD; Choi S; Park SM; Kwon JW; Jee D
    Medicine (Baltimore); 2019 Jan; 98(2):e14026. PubMed ID: 30633194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.